scholarly journals Benzodiazepines in Miami-Dade County, Florida Driving Under the Influence (DUI) Cases (1995-1998) with Emphasis on Rohypnol(R): GC-MS Confirmation, Patterns of Use Psychomotor Impairment, and Results of Florida Legislation

1999 ◽  
Vol 23 (6) ◽  
pp. 490-499 ◽  
Author(s):  
L. P. Raymon ◽  
B. W. Steele ◽  
H. C. Walls
2021 ◽  
pp. 026988112110215
Author(s):  
Tory R Spindle ◽  
Erin L Martin ◽  
Megan Grabenauer ◽  
Thomas Woodward ◽  
Michael A Milburn ◽  
...  

Background: Cannabis legalization is expanding, but there are no established methods for detecting cannabis impairment. Aim: Characterize the acute impairing effects of oral and vaporized cannabis using various performance tests. Methods: Participants ( N = 20, 10 men/10 women) who were infrequent cannabis users ingested cannabis brownies (0, 10, and 25 mg Δ-9-tetrahydrocannabinol, THC) and inhaled vaporized cannabis (0, 5, and 20 mg THC) in six double-blind outpatient sessions. Cognitive/psychomotor impairment was assessed with a battery of computerized tasks sensitive to cannabis effects, a novel test (the DRiving Under the Influence of Drugs, DRUID®), and field sobriety tests. Blood THC concentrations and subjective drug effects were evaluated. Results: Low oral/vaporized doses did not impair cognitive/psychomotor performance relative to placebo but produced positive subjective effects. High oral/vaporized doses impaired cognitive/psychomotor performance and increased positive and negative subjective effects. The DRUID® was the most sensitive test to cannabis impairment, as it detected significant differences between placebo and active doses within both routes of administration. Women displayed more impairment on the DRUID® than men at the high vaporized dose only. Field sobriety tests showed little sensitivity to cannabis-induced impairment. Blood THC concentrations were far lower after cannabis ingestion versus inhalation. After inhalation, blood THC concentrations typically returned to baseline well before pharmacodynamic effects subsided. Conclusions: Standard approaches for identifying impairment due to cannabis exposure (i.e. blood THC and field sobriety tests) have severe limitations. There is a need to identify novel biomarkers of cannabis exposure and/or behavioral tests like the DRUID® that can reliably and accurately detect cannabis impairment at the roadside and in the workplace.


2012 ◽  
Vol 3S;15 (3S;7) ◽  
pp. ES215-ES230
Author(s):  
Brian Wilhelmi

Background: Driving under the influence of drugs (DUID) is a term used to designate the action of driving an automobile after the consumption of drugs or medications other than alcohol that interfere with the capacity to operate a vehicle safely. Unlike recreational drugs, prescription medications pose a unique challenge to those attempting to harness their benefits yet protect the driving public. As studies demonstrate a steady increase in opioid use and abuse in the United States, these same constituencies must regulate a significant percentage of drivers who are under the influence of opioids. Objective: This article examines current DUID policy and attempts to present unified suggestions for improvement based on best scientific evidence of opioid-induced psychomotor impairment. Study Design: Literature Review Methods: A literature search was conducted regarding the epidemiology of opioid use and abuse, psychomotor effects of opioids, DUID, and state policy concerning DUID. A total of 23 epidemiological studies, 3 studies on acute psychomotor effects, 32 on chronic psychomotor effects, and selected pertinent law and policy were reviewed. Results: Current state law concerning DUID is variable and often relies on prosecutorial discretion to provide protection of the driving public and prosecution of the truly impaired. Limitations: The design of various studies included in this review imposes limitations on the epidemiological data extracted. Relationships between opioids and automobile accidents are commonly reviewed in retrospect. The data on opioid-induced psychomotor impairment and its effects on driving an automobile require further direct study to examine current inferences. Conclusions: A sizable percentage of the driving public has detectable levels of opioids within their bodies. The best available evidence demonstrates psychomotor impairment following acute administration of opioids or an increase in opioid dosage, but impairment diminishes with chronic, stable opioid usage. Policy makers must account for this evidence when balancing the benefit of pain relief against the need for public roadway protection when drafting DUID legislation. Key words: Driving under the influence of drugs, DUID, psychomotor impairment, opioids, regulation, automobile accident(s), driver impairment, prescription drugs, chronic opioid analgesic therapy, driving under the influence


2017 ◽  
Vol 18 (3) ◽  
pp. 359-373
Author(s):  
Eduardo Romano ◽  
Mariana Sánchez ◽  
Mario De La Rosa ◽  
Benjamin Ertman

2005 ◽  
Author(s):  
Patricia Martens ◽  
◽  
Randy Fransoo ◽  
Elaine Burland ◽  
Charles Burchill ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document